Kennedy Capital Management, Inc. Bluebird Bio, Inc. Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $1.55 Million - $1.89 Million	-85,663 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $1.42 Million - $2.9 Million	85,663 New	85,663 $2.58 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $1.31 Million - $1.73 Million	-14,742 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $67,755 - $86,761	680 Added 4.84%	14,742 $2.31 Million
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $24,439 - $34,867	-231 Reduced 1.62%	14,062 $2.4 Million
Q4 2017 Feb 13, 2018	BUY	$81.25 - $130.7 $1.16 Million - $1.87 Million	14,293	14,293 $2.55 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.